Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

17.02
+0.37002.22%
Post-market: 16.95-0.0700-0.41%19:45 EDT
Volume:8.64M
Turnover:146.44M
Market Cap:19.56B
PE:-48.03
High:17.05
Open:16.75
Low:16.67
Close:16.65
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:1.04
T/O Rate:0.76%
Dividend:0.48
Dividend Rate:2.82%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.37
PE(LYR):-5.67

Loading ...

GUIDANCE: (VTRS) Viatris Expects 2026 Adjusted EPS Range $2.45 - $2.59, vs. FactSet Est of $2.45

MT Newswires Live
·
Aug 06

Harrow to Buy Dry Eye Nasal Spray Tyrvaya from Viatris for up to $100 Million

Reuters
·
Aug 06

Opus Genetics Q2 FY26 Net Loss Widens to $8.1 Million; Revenue Drops to $755,000

Reuters
·
Aug 06

Viatris Q2 FY26 Net Loss Widens to $119 Million; Revenue Rises 5% to $3.8 Billion

Reuters
·
Aug 06

Viatris Q2 Adj. EPS $0.69 Beats $0.60 Estimate, Sales $3.756B Beat $3.675B Estimate

Benzinga Earnings
·
Aug 06

Viatris Q2 Adjusted EPS USD 0.69 Vs. IBES Estimate USD 0.6

Reuters
·
Aug 06

Viatris - Raises 2026 Financial Guidance Midpoints for All Metrics

THOMSON REUTERS
·
Aug 06

Viatris Inc Expected to Post Earnings of 60 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Viatris Declares Quarterly Dividend of $0.12 a Share

Reuters
·
Aug 04

Viatris Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 01

Earning Preview: Viatris Inc. revenue this quarter is expected to increase by 6.09%, and institutional views are predominantly bullish

Earnings Agent
·
Jul 31

Viatris receives FDA approval for Gwyn Lo contraceptive patch

TIPRANKS
·
Jul 29

Viatris - Expects Gwyn Lo to be Available Later This Year

THOMSON REUTERS
·
Jul 29

Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch

THOMSON REUTERS
·
Jul 29

J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)

TIPRANKS
·
Jul 28

Viatris Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jul 24

Viatris Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jul 23

Goldman Sachs Adjusts Price Target on Viatris to $18 From $17, Maintains Neutral Rating

MT Newswires Live
·
Jul 22

UBS Reaffirms Their Buy Rating on Viatris (VTRS)

TIPRANKS
·
Jul 22